HighMark Wealth Management’s Zimmer Biomet ZBH Stock Holding History

HighMark Wealth Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.58K	Buy	+30	New	+$2.63K	﹤0.01%	446
2024 Q1	–	Sell	-38	Closed	-$4.63K	–	614
2023 Q4	$4.63K	Hold	38	–	–	﹤0.01%	380
2023 Q3	$4.26K	Sell	38 -27	-42%	-$3.43K	﹤0.01%	372
2023 Q2	$9.46K	Hold	65	–	–	0.01%	266
2023 Q1	$8.4K	Hold	65	–	–	0.01%	320
2022 Q4	$8.29K	Buy	65 +3	+5%	+$348	0.01%	279
2022 Q3	$6K	Hold	62	–	–	0.01%	319
2022 Q2	$7K	Sell	62 -3	-5%	-$356	0.01%	311
2022 Q1	$8K	Buy	+65	New	+$7.83K	0.01%	313
2020 Q4	–	Sell	-670	Closed	-$88K	–	486
2020 Q3	$88K	Hold	670	–	–	0.08%	70
2020 Q2	$78K	Buy	+670	New	+$77.2K	0.09%	61

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HighMark Wealth Management's ZBH Position: Q2 2026 in Review

HighMark Wealth Management opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 30 shares worth $2.58K. The stake represents ﹤0.01% of the portfolio and ranks #446 among its holdings. This is a return to the name: HighMark Wealth Management previously reported a position in ZBH as recently as Q4 2023.

HighMark Wealth Management first reported a position in ZBH in Q2 2020 and has held it in 11 quarters since. The position peaked at $88K in Q3 2020. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

HighMark Wealth Management held 30 shares of Zimmer Biomet worth $2.58K as of Q2 2026.
Zimmer Biomet was a new HighMark Wealth Management position in Q2 2026.
Zimmer Biomet made up ﹤0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #446 holding.
HighMark Wealth Management first reported a position in Zimmer Biomet in Q2 2020 and has held it in 11 quarters since.
HighMark Wealth Management's Zimmer Biomet position peaked at $88K in Q3 2020.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.